or Try an Advanced Search...

    Hepatitis C Virus Infection Stocks List

    Symbol Grade Name % Change
    RGLS B Regulus Therapeutics Inc. -1.49
    IONS F Ionis Pharmaceuticals, Inc. -2.60
    BMY F Bristol-Myers Squibb Company 0.66
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis C Hepatitis C Virus Biopharmaceutical Diabetes Dystrophy Genetics Hepatitis B Hepatitis B Virus Lipodystrophy Treatment Of Diabetes Acromegaly Alcohol Alnylam Pharmaceuticals Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Atherosclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis C Virus Infection stocks.

    Symbol Grade Name Weight
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 7.16
    MEDX F Horizon Kinetics Medical ETF 5.43
    WBIY D WBI Power Factor High Dividend ETF 4.72
    ARKG D ARK Genomic Revolution Multi-Sector ETF 4.52
    XPH D SPDR S&P Pharmaceuticals ETF 4.05
    View all Hepatitis C Virus Infection ETFs...
    Compare ETFs
    Compare ARKG to XPH Compare FTXH to MEDX Compare FTXH to XPH

        Hepatitis C Virus Infection Stocks Recent News

        Date Stock Title
        May 4 BMY Pharma R&D productivity seen improving for the first time in years - Deloitte
        May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
        May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
        May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
        May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
        May 3 BMY Bristol-Myers Squibb: A Lost Decade?
        May 2 BMY Schrodinger gets rights to cancer drug candidate back from Bristol
        May 2 BMY Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 1 BMY Editas, Bristol Myers extend T cell therapy collaboration
        May 1 IONS 4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 1 BMY Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
        Apr 30 BMY Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
        Apr 30 IONS Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
        Apr 30 BMY J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations
        Apr 30 RGLS Regulus Therapeutics to Participate in the Canaccord Genuity Genetic Medicine for Generalists Webcast Series
        Apr 30 BMY Bristol Myers Squibb: Tough Times Continue
        Apr 29 BMY J&J, Bristol Myers lose challenges to US drug price negotiation program
        Apr 29 BMY Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact
        Apr 29 BMY Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
        Apr 29 BMY Repertoire pivot pays dividends with Bristol Myers deal
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis C Hepatitis C Virus Biopharmaceutical Diabetes Dystrophy Genetics Hepatitis B Hepatitis B Virus Lipodystrophy Treatment Of Diabetes Acromegaly Alcohol Alnylam Pharmaceuticals Alport Syndrome Amyloid Amyloidosis Angioedema Antisense RNA Apatorsen Atherosclerosis
        Hepatitis C Virus Infection

        Hepatitis C virus (HCV) infection is a contagious liver disease caused by the hepatitis C virus. It is spread through contact with the blood of an infected person. Symptoms of HCV infection can range from mild to severe and may include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored stools, joint pain, and jaundice. In some cases, HCV infection can lead to serious liver problems, including cirrhosis and liver cancer. Treatment for HCV infection typically involves a combination of antiviral medications.

        Browse All Tags